Recent advances and expanding applications of organoid models in unveiling drug ADME profiles
Guolei Zhang, Ruifan Zhang, Zihang Shu, Jing Zhao, Lei Yin, Meiyun Shi, Yanshuo Han · 2026
Read Recent advances and expanding applications of organoid models in unveiling drug ADME profiles by Guolei Zhang, Ruifan Zhang, Zihang Shu, Jing Zhao, Lei Yin, Meiyun Shi, Yanshuo Han (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13315687.txt.
Description
Guolei Zhang and colleagues review, in a 2026 paper, how organoid models are changing drug uptake, spread, breakdown, and removal research. Organoids are three-dimensional models grown from stem or progenitor cells that mimic the structure and function of human organs. They promise better predictions than flat cell cultures or animal models, which suffer physiological mismatch and species differences. The review focuses on liver and intestinal systems.
Models improve predictions of oral uptake, help assess drug-drug interactions, and clarify why drug processing varies between people. Current limits include incomplete maturation, lack of standards, and limited blood vessels. The authors look ahead to models joined with organ-on-a-chip systems and artificial intelligence. With refinement, they expect organoid approaches to raise drug development efficiency and clinical translation accuracy, advancing drug science and personalized medicine.
Catalog record
| CREATOR | Guolei Zhang, Ruifan Zhang, Zihang Shu, Jing Zhao, Lei Yin, Meiyun Shi, Yanshuo Han |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 120 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |